Ozempic was found in a 2025 clinical trial to reduce measurable biological age in adults by approximately 3 to 5 years — with improvements in inflammation, cardiovascular health, and kidney function
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Ozempic was found in a 2025 clinical trial to reduce measurable biological age in adults by approximately 3 to 5 years — with improvements in inflammation, cardiovascular health, and kidney function" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Medical News Today, Conexiant, Yahoo and University of California. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 135d ago.
Quick answers
Why is "Ozempic was found in a 2025 clinical trial to reduce measurable biological age i" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Semaglutide, omega-3s and diet shift epigenetic aging clocks in human studies News-Medical · 135d ago
- UC San Diego researchers explore whether a GLP-1 drug can slow biological aging KPBS · 135d ago
- Semaglutide and aging: New study finds benefits beyond weight loss Medical News Today · 135d ago
- Semaglutide Tied to Aging Clocks in HIV Conexiant · 135d ago
- Weight loss drugs show signs of slowing biological aging, scientists discover Yahoo · 135d ago
- New study shows popular GLP-1 weight loss drug may slow biological aging University of California · 135d ago
- Ozempic was found in a 2025 clinical trial to reduce measurable biological age in adults by approximately 3 to 5 years — with improvements in inflammation, cardiovascular health, and kidney function Space Daily · 135d ago
Topics
Related trends
New weight loss drug proves twice as powerful as Ozempic’s highest dosage
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Lilly's Retatrutide Trounces Ozempic In Head-To-Head Study
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Retatrutide beats Ozempic on weight loss, blood sugar control, study says
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss
Eli Lilly reports that its new drug, retatrutide, achieved more than double the weight loss of Ozempic's highest approved dose in a head-to-head trial.
15% Of Americans Have Taken A GLP-1, And Dermatologists Now Have A Timeline For When The Hair Goes
Recent studies link popular GLP-1 weight-loss drugs to unexpected dermatological side effects like nail detachment and hair loss.
Patient-Reported Changes in Alcohol Use Following GLP-1 RA Initiation
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.